ReSound OMNIA miniRIE vs Sontro Soundwave

The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.

The Sontro Soundwave is a mid-priced OTC hearing aid that earns a B grade with a SoundScore of 3.0/5 in our lab testing. At $849, this behind-the-ear device uses disposable batteries and sits in the lower tier of OTC performance, ranking #61 of 65 devices in its category. The Soundwave's strongest attribute is own-voice comfort, scoring 3.6/5—a solid result that sits 1.09 points above the OTC category average. This makes it relatively comfortable for wearers who are sensitive to hearing their own voice sound unnatural or boomy. However, other performance areas present significant limitations. Speech clarity scores are below average in both quiet and noisy environments. Speech in quiet scores 2.7/5 (0.12 points below average), while speech in noise drops to 1.2/5 (0.28 points below average). Feedback handling is a notable weakness at 2.5/5, falling 2.04 points below the category average of 4.54/5. Perhaps most limiting is the music streaming score of 0.0/5, indicating this device does not support phone audio streaming—a feature many competitors in this price range offer. Consumers prioritizing own-voice comfort on a moderate budget may find the Soundwave acceptable, but those seeking strong speech clarity or streaming capability should consider alternatives. Several higher-performing OTC devices are available at similar or lower price points, including options like the Lexie Lumen or HearingAssist Control that deliver comparable or better overall sound quality.